Bottom line
XLV vs TMED: the short answer
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and TMED (T. Rowe Price Health Care ETF) share a meaningful slice of their top holdings — about 47% by weight.
XLV is cheaper at 0.08% vs 0.44% — a difference of $36 a year per $10,000 invested.
Updated Nov 19, 2026
XLV vs TMED side by side
| XLV | TMED | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.08% | 0.44% |
| Annual cost per $10k | $8 | $44 |
| 10-yr cost on $10k (prospectus) | $103 | $555 |
| Max front load | None | None |
| 12b-1 fee | 0.02% | — |
| 1-yr return | +14.5% | — |
| 5-yr return (annualized) | +8.1% | — |
| 10-yr return (annualized) | +9.8% | — |
| Best quarter | +14.5% | — |
| Worst quarter | −12.7% | — |
| Net assets (fund) | $40.6B | $23.0M |
| Number of holdings | 65 | 102 |
| Portfolio turnover | 2% | 44% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of XLV's top 25 holdings also appear in TMED's top 25.
| Holding | XLV | TMED |
|---|---|---|
| Eli Lilly & Co | 16.51% | 16.71% |
| UnitedHealth Group Inc | 6.57% | 6.52% |
| Thermo Fisher Scientific Inc | 3.24% | 4.11% |
| Gilead Sciences Inc | 2.73% | 4.44% |
| Intuitive Surgical Inc | 2.45% | 2.43% |
| Pfizer Inc | 2.39% | 1.91% |
| Danaher Corp | 2.09% | 2.96% |
| Stryker Corp | 1.89% | 2.22% |
| McKesson Corp | 1.58% | 1.46% |
| Cencora Inc | 0.96% | 2.75% |
Source: SEC Form N-PORT
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
TMED top 10
- Eli Lilly & Co — 16.71%
- Unitedhealth Group Inc — 6.52%
- Gilead Sciences Inc — 4.44%
- Thermo Fisher Scientific Inc — 4.11%
- Danaher Corp — 2.96%
- Cencora Inc — 2.75%
- Agilent Technologies Inc — 2.61%
- Alnylam Pharmaceuticals Inc — 2.60%
- Intuitive Surgical Inc — 2.43%
- Insulet Corp — 2.38%
FAQ
What is the difference between XLV and TMED?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and TMED (T. Rowe Price Health Care ETF) share a meaningful slice of their top holdings — about 47% by weight. XLV is cheaper at 0.08% vs 0.44% — a difference of $36 a year per $10,000 invested.
Which is cheaper, XLV or TMED?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and TMED?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.